David Greydinger, DC in Atlantis, FL - Chiropractor

David Greydinger, DC is a Chiropractor based in Atlantis, Florida. David Greydinger is licensed to practice in Florida (license number CH9091) and his current practice location is 5913 S Congress Ave, Atlantis, Florida. He can be reached at his office (for appointments etc.) via phone at (561) 296-5243.

NPI number for David Greydinger is 1821148057 and his current mailing address is 240 188th St, Sunny Isles Beach, Florida. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1821148057.

Contact Information

	David Greydinger, DC
	5913 S Congress Ave, Atlantis, FL 33462-1303
	(561) 296-5243
	Not Available

Healthcare Provider's Profile

Full Name	David Greydinger
Gender	Male
Speciality	Chiropractor
Location	5913 S Congress Ave, Atlantis, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1821148057
Provider Enumeration Date: 01/11/2007
Last Update Date: 04/25/2012

Medical Identifiers

Medical identifiers for David Greydinger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821148057	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	CH9091 (Florida)	Primary
111N00000X	Chiropractor	009225 (New York)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Greydinger is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Greydinger, DC 240 188th St, Sunny Isles Beach, FL 33160-2436 Ph: () -	David Greydinger, DC 5913 S Congress Ave, Atlantis, FL 33462-1303 Ph: (561) 296-5243

News Archive

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.

Michael Parkinson becomes a 'dignity' ambassador for the elderly

An initiative by the British Government to encourage more respect for older people in care has been given added impact by the recruitment of TV talk show host Sir Michael Parkinson as a "dignity ambassador".

Winter grips Scotland with unprecedented rise in health concerns

Over three days of festivities Scotland's NHS 24 has received almost 30,000 calls. This made 27th of December NHS 24's busiest day since January 2007. The surge in demand for the service was due to the closure of GP surgeries over the festive weekend.

Natural-shaped plastic nanoparticles could improve delivery of toxic drugs to tumors

UNSW Sydney scientists have developed a way to control the shape of polymer molecules so they self-assemble into non-spherical nanoparticles - an advance that could improve the delivery of toxic drugs to tumors.

David Greydinger, DC - Chiropractor in Atlantis, FL